Association between immunosuppressive medications and COVID-19 hospitalisation and death: a retrospective cohort study
Importance Immunocompromised status is a risk factor for severe SARS-CoV-2 infection. Little is known about how systemic corticosteroid dose and concurrent use of immunosuppressants are associated with COVID-19 outcomes.Objective To assess the association between corticosteroid dose/duration and con...
Saved in:
| Main Authors: | Nisha R Acharya, Benjamin F Arnold, Samantha J Sechrist, Emily Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2024-12-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/14/12/e087467.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk factors for COVID-19 hospitalisations and deaths in Mexican children and adolescents: retrospective cross-sectional study
by: Mauricio Hernandez-Avila, et al.
Published: (2022-06-01) -
Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study
by: Aziz Sheikh, et al.
Published: (2022-12-01) -
Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
by: Krishnan Bhaskaran, et al.
Published: (2022-01-01) -
Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City
by: Girish N Nadkarni, et al.
Published: (2020-11-01) -
Ethnicity and risk of death in patients hospitalised for COVID-19 infection in the UK: an observational cohort study in an urban catchment area
by: Elizabeth Sapey, et al.
Published: (2020-09-01)